Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms
RESEARCH TRIANGLE PARK, N.C., Feb. 16, 2023 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company has entered into a Memorandum of Understanding (“MoU”) with KARL STORZ VentureONE Pte. Ltd. (“KARL STORZ”), a wholly owned subsidiary of KARL STORZ SE & Co. KG, a global leader in the medical technologies industry, especially in the area of endoscopes, medical instruments, and devices that offers state-of-the-art technology for minimally invasive procedures in virtually all surgical specialties. As a solution-oriented and innovative partner, the independent family-owned company is in close collaboration with surgeons and health care partners around the globe to enable them to perform at their very best every day to improve patients’ lives.